v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2026
Sep. 30, 2025
CURRENT ASSETS:    
Cash $ 94,808 $ 37,231
Prepaid expense 81,954 8,591
Total Current Assets 176,762 45,822
Total Assets 176,762 45,822
CURRENT LIABILITIES:    
Convertible note payable, net 20,000
Financing liability 31,601
Accrued interest 83,400 57,026
Accounts payable and accrued expenses 116,641 366,899
Accrued compensation and related expenses 703,328 781,392
Advances from related parties 84,137 84,137
SBA loan 48,750 48,750
Total Current Liabilities 1,067,857 1,358,204
Total Liabilities 1,067,857 1,358,204
STOCKHOLDERS' DEFICIT:    
Common stock, $0.001 par value; 300,000,000 shares authorized; 35,954,787 and 34,430,605 shares issued and outstanding at March 31, 2026 and September 30, 2025, respectively 35,707 29,927
Additional paid-in capital 26,570,440 25,148,936
Less: series B preferred stock held in treasury, at cost; 502,512 shares at March 31, 2026 and September 30, 2025 (300,000) (300,000)
Accumulated deficit (27,199,153) (26,193,306)
Total Stockholders' Deficit (891,095) (1,312,382)
Total Liabilities and Stockholders' Deficit 176,762 45,822
Series A Preferred Stock [Member]    
STOCKHOLDERS' DEFICIT:    
Preferred stock, value
Series B Preferred Stock [Member]    
STOCKHOLDERS' DEFICIT:    
Preferred stock, value $ 1,911 $ 2,061